(Date:11/20/2008)...ng is everything, and that certainly appears to be...ur months before the height of cold and flu season...a than children born at any other time of year, ac...he birth and medical records of more than 95,000 c...e whether date of birth in relationship to the pea...
(Date:11/20/2008)... NOVEMBER 2008 The consumption of illicit or nonc...worldwide and contributes significantly to the glo...eleased today by the International Center for Alco... of noncommercial alcohol, defined as traditional ... local trade and counterfeit or unregistered produ...
(Date:11/20/2008)...g could be key to new disease-fighting therapies ,... New research on mice suggests inhibiting a protei...ove to be key to cancer-fighting treatments. , ...rsite catholique de Louvain, in Belgium, found tha... on whether they are in regions rich in oxygen or ...
(Date:11/20/2008)...RNewswire-USNewswire/ -- The National Minority Qua...ical Association,s recent decision to develop a He...an and patient advocates to join the Forum in enco...e plans. , , "Physicians and lawyers -- eve.... Puckrein, PhD, President and Chief Executive Off...
Breaking Medicine News(10 mins):Health News:Fall babies: Born to wheeze? 2Health News:Report finds extensive use of illicit alcohol 2Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2...ublished a research report on recommendations to i...lth-worker performance is a widespread problem for...t issue of The Lancet researchers had reviewed the...endations for how high-quality health-worker perfo...
... the day when it will be possible to correct the e...h normal ones. Gene therapy refers to the treatmen...es into abnormal cells. The hope is that the trans...t rather than merely alleviating its damage. Getti...
...the direction that a dose of stress everyday can s...evels of daily stress are linked to a decreased ri...udy carried out at the National Institute of Publi...f over 6,500 women were followed for 18 years and ...
...sclerosis (MS) may gain from treatment with Interf...ent with interferon appears to reduce the formatio... with multiple sclerosis (MS), including lesions t...called black holes, on magnetic resonance imaging ...
Other Medicine News:Health News:Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement 2Health News:Patients Of MS Are Not At Risk From The Interferon Treatment 2(Date:11/19/2008)...19 Posit Science Corporation,rese...ety for Neuroscience,Annual Conference in Washing...ing may benefit Baby Boomers. The computerized br...ses adaptive exercises that target auditory and,l...ive generalized,improvements in cognition by impr...
(Date:11/19/2008)...report basic findings on critical enzyme,s regulat...eat an array of disorders , , MEMPHIS, Tenn...at St. Jude Children,s Research Hospital have gain...,s enzyme workhorses called calpains. , , ...nction in many cellular processes, including the m...
(Date:11/19/2008)... Payment from Roche- , , MONTVALE, N.J., No...cals Corp. (Nasdaq: MEMY ) today announced that ...2 trial of R3487/MEM 3454, its lead alpha-7 nicoti...ciated with schizophrenia (CIAS). The Company has...ggering a $5.0 million payment from its partner Ro...
(Date:11/18/2008)...8 Arlington Medical Resources (AMR...the pharmaceutical and diagnostic,imaging industr...Privigen was,sold in the U.S. during the third qu...travenous immune globulin (IVIG) and was launched ...reated from the blood plasma of thousands,of dono...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Strike at Millbrae Nursing Home Called Off 16792 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 2Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy 1778 1Forests long term potential for carbon offsetting 2888 1Forests long term potential for carbon offsetting 2888 2...l pain relief within 5,minutes of dosing and is we...himedes Pharma Ltd,("Archimedes"), a European spec...clinical data from a Phase II study of Nasalfent(r...d at providing a,fast, effective and convenient tr...esented at the 10th Congress of the European,Assoc...
... SR as a novel component in,EMPATIC(TM) Phase IIb ...e-FirstCall/ -- Orexigen(TM),Therapeutics, Inc. , ...nt of central nervous system disorders with an ini...m a Phase I trial evaluating,safety and pharmacoki...e (SR) formulation of zonisamide. In the study, th...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4... of the most modern lithotripters available today ...om being designed for the treatment of the entire ...LITH SLX can also be employed for a variety of oth...e for the treatment of gallstones or for orthopead...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only.
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: